Cancer Research UK logo.
SearchDonate
  • Search

A trial of camizestrant for breast cancer (SERENA 6)

Overview

Cancer types:

Breast cancer

Status:

Closed

Phase:

Phase 3

Details

This trial is looking at camizestrant (AZD9833) with a for breast cancer. It is for people with breast cancer that has come back in the same area or spread to another part of the body.

It is open to people with breast cancer who are doing well on their current treatment and their cancer has:

  • a large number of receptors for the hormone oestrogen () and

  • a small number of the protein (HER 2 negative)

Recruitment start: 21 October 2021

Recruitment end: 12 June 2024

How to join

Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Richard Baird

Supported by

AstraZeneca

Last reviewed: 14 Jul 2024

CRUK internal database number: 17761

Help and support